NEW YORK (GenomeWeb News) - GeneGo said today that Siena Biotech has expanded its collection of MetaCore licenses by an undisclosed amount.
Siena is using the MetaCore technology to integrate multiple data types including proteomics and chemogenomics information.
Financial terms were not disclosed.
Other customers have recently extended their licenses with GeneGo, such as NHLBI in June and Merck in January.